trending Market Intelligence /marketintelligence/en/news-insights/trending/w_sj5cd9tnded_2awtqwlw2 content esgSubNav
In This List

HLS Therapeutics names CFO

Video

S&P Capital IQ Pro | Powering Your Edge

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


HLS Therapeutics names CFO

HLS Therapeutics Inc. appointed Tim Hendrickson as CFO, effective Sept. 6.

Hendrickson previously was the company's vice president of finance and administration, a position he has held since 2015.

Toronto-based HLS Therapeutics acquires and distributes in North American markets pharmaceutical products for the central nervous system and cardiovascular specialties.